Juno Therapeutics, Inc.
Overview
Juno Therapeutics, Inc. is a subsidiary of Bristol-Myers Squibb Company that focuses on developing innovative immunotherapies for the treatment of cancer. The company leverages advanced technologies to enhance the body’s immune system in targeting cancer cells.
Therapeutic areas
FDA compliance signals
3 FDA enforcement records linked to this company.
- 4832023-09-20
Procedures not in writing, fully followed
- 4832023-09-20
Procedures for sterile drug products
- 4832023-09-20
Written procedures not established/followed
Is this Juno Therapeutics, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.